Insufficient scRNA-seq data for expression of ASB4 at single-cell level.
Insufficient scRNA-seq data for expression of ASB4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 7261.78 | 258 / 258 | 40% | 30.66 | 93 / 230 |
| brain | 87% | 192.74 | 2307 / 2642 | 37% | 0.77 | 258 / 705 |
| muscle | 100% | 1254.63 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 71% | 107.99 | 612 / 861 | 0% | 0 | 0 / 0 |
| liver | 42% | 32.01 | 95 / 226 | 27% | 1.15 | 111 / 406 |
| lung | 39% | 26.86 | 226 / 578 | 14% | 0.96 | 162 / 1155 |
| skin | 15% | 8.50 | 263 / 1809 | 33% | 6.01 | 158 / 472 |
| ovary | 44% | 35.17 | 80 / 180 | 2% | 0.07 | 10 / 430 |
| pancreas | 23% | 12.82 | 77 / 328 | 11% | 0.62 | 20 / 178 |
| kidney | 24% | 22.87 | 21 / 89 | 8% | 0.34 | 69 / 901 |
| breast | 27% | 17.35 | 124 / 459 | 3% | 0.07 | 34 / 1118 |
| esophagus | 1% | 0.59 | 13 / 1445 | 14% | 3.70 | 25 / 183 |
| stomach | 3% | 1.58 | 9 / 359 | 12% | 2.33 | 34 / 286 |
| intestine | 2% | 1.10 | 19 / 966 | 12% | 1.07 | 65 / 527 |
| thymus | 6% | 3.22 | 41 / 653 | 8% | 0.15 | 46 / 605 |
| uterus | 5% | 3.28 | 9 / 170 | 7% | 0.54 | 31 / 459 |
| prostate | 9% | 4.92 | 23 / 245 | 1% | 0.03 | 6 / 502 |
| bladder | 5% | 5.29 | 1 / 21 | 5% | 0.43 | 23 / 504 |
| adipose | 9% | 4.82 | 111 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
| blood vessel | 1% | 1.63 | 15 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 0.48 | 5 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_2001214 | Biological process | positive regulation of vasculogenesis |
| GO_0051865 | Biological process | protein autoubiquitination |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0031466 | Cellular component | Cul5-RING ubiquitin ligase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0031462 | Cellular component | Cul2-RING ubiquitin ligase complex |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
| GO_0031625 | Molecular function | ubiquitin protein ligase binding |
| Gene name | ASB4 |
| Protein name | Ankyrin repeat and SOCS box protein 4 (ASB-4) |
| Synonyms | |
| Description | FUNCTION: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Promotes differentiation and maturation of the vascular lineage by an oxygen-dependent mechanism (By similarity). . |
| Accessions | Q9Y574 ENST00000428113.5 [Q9Y574-2] ENST00000325885.6 [Q9Y574-1] |